Evidence map›Paper›PMID 42505460›Full record

ReviewBiosensors2026

Nanomaterial-Assisted Physical Mass Loading and Signal Amplification Strategies for Exosome Isolation and Sensing in Liquid Biopsy: A Review.

Sumedha Nitin Prabhu

Abstract readReview
In one paragraph

Review in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Sumedha Nitin PrabhuBiomedical Science & Engineering Programme, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.ORCID 0000-0001-7782-7514

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exosomes and small extracellular vesicles are promising liquid-biopsy biomarkers because they carry molecular information from their cells of origin and can be accessed from minimally invasive biofluids. Reliable separation and detection are made more difficult by their small size, low abundance, diverse composition, and co-occurrence with lipoproteins, protein aggregates, and other extracellular particles. To improve exosome enrichment, capture, and sensing, nanomaterial-assisted techniques have become crucial. Using a mechanism-based approach that differentiates between non-gravimetric signal amplification and genuine physical mass loading, this study offers an organized comparison of nanomaterial-enabled exosome sensing techniques. This distinction is helpful because different transducers measure different physical quantities: while optical, electrochemical, fluorescent, catalytic, and nucleic acid-based platforms typically benefit from enhanced signal generation rather than increased mass, resonant and gravimetric sensors benefit from increased inertial or surface-bound mass. In terms of amplification mechanism, transducer compatibility, sample-matrix tolerance, workflow complexity, and translational maturity, the review contrasts metallic nanoparticles, magnetic systems, metal-organic frameworks, carbon and two-dimensional materials, quantum dots, upconversion nanomaterials, DNA nanostructures, and polymer-based platforms. The gap between analytical sensitivity and clinical utility, including separation purity, recovery, biological heterogeneity, pre-analytical variability, interference from complex biofluids, and the need for uniform validation, is given special focus. The review concludes that no single nanomaterial or amplification method is universally optimal; instead, platform-aware, application-specific integration of isolation, amplification, and validation techniques is necessary for clinically meaningful exosome sensing.

Indexed as

Biosensing TechniquesExosomesNanostructuresHumansLiquid Biopsybiosensorsclinical translationexosome isolationexosomesextracellular vesiclesliquid biopsymatrix effectsnanomaterial-assisted sensingnon-gravimetric signal amplificationphysical mass loading

Identifiers

PMID42505460
PMCPMC13406625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.